Newbury Park, CA, United States of America

Kenneth William Walker

This inventor holds 39 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Biotherapeutics Development. Top assignees: Amgen Inc., Other. Active years: 1998-2026.

USPTO Granted Patents = 39 (Patent Applications = 16)

% Patents Active = 79.5

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 4.0

ph-index = 10

Forward Citations = 326(Granted Patents)

Location History:

Fairdale, KY (US) (1998)
Lake Park, FL (US) (2015)
Newbury Park, CA (US) (2010 - 2024)

Company Filing History:

36 out of 2,065

Amgen Inc.

patents

3 out of 834,307

Other

patents

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

GDF-15 Polypeptides

Anti-TL1A Antibodies

Therapeutic Peptides

Fc Molecules

Toxin Peptide Agents

CGRP Antagonists

Immunoglobulin Fusions

PAC1 Antibodies

Thrombopoietic Compounds

Bioconjugates

Metabolic Disorders

Fingerprint Recognition

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552877 - Anti-TL1A antibodies and uses thereof (2026-02-17),

2. 12465652 - Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (GIPR)/GLP-1 receptor agonist fusion proteins (2025-11-11),

3. 12269898 - Transthyretin immunoglobulin fusions (2025-04-08),

4. 12054527 - Growth differentiation factor 15 fusion proteins (2024-08-06),

5. 11891435 - Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof (2024-02-06),

6. 11739131 - Growth differentiation factor 15 (GDF-15) polypeptides (2023-08-29),

7. 11266744 - Modified Fc molecules (2022-03-08),

8. 11248043 - Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof (2022-02-15),

9. 11161889 - Growth differentiation factor 15 fusion proteins (2021-11-02),

10. 11104745 - Anti-TL1A/anti-TNF-alpha bispecific antigen binding proteins and uses thereof (2021-08-31),

11. 10894814 - Growth differentiation factor 15 (GDF-15) constructs (2021-01-19),

12. 10738110 - PAC1 antibodies and uses thereof (2020-08-11),

13. 10336798 - Growth differentiation factor 15 (GDF-15) polypeptides (2019-07-02),

14. 10189912 - Carrier immunoglobulins (2019-01-29),

15. 10188740 - Modified Fc molecules (2019-01-29),

Title: The Innovative Journey of Kenneth William Walker

Introduction: Kenneth William Walker, a visionary inventor based in Newbury Park, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Kenneth William Walker's latest patents include a cutting-edge virtual reality headset that revolutionizes the gaming industry, a solar-powered device for sustainable energy solutions, and a smart home automation system for enhanced convenience and security.

Career Highlights: With a career spanning over two decades, Kenneth William Walker has established himself as a leading figure in the world of innovation. His work has been recognized for its creativity, practicality, and positive impact on society.

Collaborations: Throughout his career, Kenneth William Walker has collaborated with top technology companies, research institutions, and universities to bring his inventions to life. His partnerships have led to the development of groundbreaking products that have shaped the future of technology.

Conclusion: Kenneth William Walker's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor. His dedication to creating solutions that improve lives and push the boundaries of technology continues to inspire the next generation of inventors.